February 23, 2022
Researchers recently began phase one clinical trials of a domestically produced COVID-19 candidate vaccine, a development that may bring the country closer to producing its first homegrown coronavirus jab.
Indonesia begins clinical trials of homegrown COVID-19 candidate vaccine
Researchers recently began phase one clinical trials of a domestically produced COVID-19 candidate vaccine, a development that may bring the country closer to producing its first homegrown coronavirus jab.
